Characterization of deletional and non-deletional alpha globin variants in a large cohort from Spain between 2009 and 2014 Félix de la Fuente-GonzaloJorge M. NietoPaloma Ropero Original Article 25 April 2019 Pages: 1537 - 1545
Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and/or paroxysmal nocturnal haemoglobinuria (QLQ-AA/PNH)—a report on phase III Cathrin NiedeggenSusanne SingerJens Panse Original Article Open access 21 May 2019 Pages: 1547 - 1559
Reduced peripheral blood superoxide dismutase 2 expression in sickle cell disease Iakovos ArmenisVassiliki KalotychouIoannis Rombos Original Article 16 May 2019 Pages: 1561 - 1572
Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries Miriam LeviMonica SimonettiFrancesco Lapi Original Article 09 May 2019 Pages: 1573 - 1582
Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density Ersi VoskaridouIoannis Ntanasis-StathopoulosEvangelos Terpos Original Article 30 April 2019 Pages: 1583 - 1592
Increased endothelial activation in α-thalassemia disease Pankamol SirivadhanakulAmpaiwan ChuansumritNongnuch Sirachainan Original Article 05 April 2019 Pages: 1593 - 1602
The platelet NLRP3 inflammasome is upregulated in a murine model of pancreatic cancer and promotes platelet aggregation and tumor growth Brian A. BoonePranav MurthySebastian Vogel Original Article 24 April 2019 Pages: 1603 - 1610
Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis Paolo StratiMaen AbdelrahimAla Abudayyeh Original Article 15 May 2019 Pages: 1611 - 1616
Pediatric Langerhans cell histiocytosis: the impact of mutational profile on clinical progression and late sequelae D. NannP. SchneckenburgerI. Bonzheim Original Article 28 March 2019 Pages: 1617 - 1626
Assessment of chronic renal injury in patients with chronic myeloid leukemia in the chronic phase receiving tyrosine kinase inhibitors Xin RenYazhen QinQian Jiang Original Article 14 May 2019 Pages: 1627 - 1640
CSF3R mutations were associated with an unfavorable prognosis in patients with acute myeloid leukemia with CEBPA double mutations Long SuSuJun GaoWei Li Original Article 30 April 2019 Pages: 1641 - 1646
Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin Motoko YamaguchiRitsuro SuzukiNaoyuki Katayama Original Article 19 April 2019 Pages: 1647 - 1655
Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma Jaewon HyungJung Yong HongCheolwon Suh Original Article 15 April 2019 Pages: 1657 - 1664
Interim PET-CT–guided therapy in elderly patients with Hodgkin lymphoma—a retrospective national multi-center study O. S. BenturE. J. DannChava Perry Original Article 18 May 2019 Pages: 1665 - 1674
Mucosa-associated lymphoid tissue lymphoma with t(11;18)(q21;q21) translocation: long-term follow-up results Kosuke ToyodaAkiko Miyagi MaeshimaYukio Kobayashi Original Article 28 March 2019 Pages: 1675 - 1687
Multiple myeloma in elderly patients—a Portuguese multicentric real-life study Cristina JoãoRui BergantimPaulo Lúcio Original Article 08 April 2019 Pages: 1689 - 1701
Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma Shuji OzakiHiroshi HandaKazuyuki Shimizu Original Article 02 May 2019 Pages: 1703 - 1711
PD-L1, LAG3, and HLA-DR are increasingly expressed during smoldering myeloma progression Alberto MussettiAlessio PellegrinelliVittorio Montefusco Original Article 03 May 2019 Pages: 1713 - 1720
Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy Huiwen JiangLin LiuYu Hu Original Article 04 May 2019 Pages: 1721 - 1732
Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantation Xuan CaiJin WuXiao-Hui Zhang Original Article 03 May 2019 Pages: 1733 - 1742
Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin’s lymphoma Young-Woo JeonSeugyun YoonSeok-Goo Cho Original Article Open access 14 May 2019 Pages: 1743 - 1753
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT Martin Schmidt-HieberGloria TridelloJan Styczynski Original Article 16 April 2019 Pages: 1755 - 1763
The benefit of chronic graft-versus-host disease in patients with acute myeloid leukemia relapsed after allogeneic stem cell transplantation Ziwei WangChunrong YinJianmin Wang Original Article 16 April 2019 Pages: 1765 - 1773
Isolated extramedullary leukemic involvement of the heart presenting as fulminant heart failure Maria StamouliKonstantinos GkirkasPanagiotis Tsirigotis Letter to the Editor 11 March 2019 Pages: 1775 - 1776
The prognostic value of geriatric nutritional risk index in patients with follicular lymphoma Kota MizunoTomonori NakazatoTakehiko Mori Letter to the Editor 30 April 2019 Pages: 1777 - 1779
Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation Ryo ShimizuMasahiro TakeuchiShinichiro Okamoto Letter to the Editor 22 May 2019 Pages: 1781 - 1783
Diffuse large B cell lymphoma with chromosomal translocation t(14;19)(q32;q13) occurring in IgG4-related disease Yuka KawajiHiroaki NagataJunya Kuroda Letter to the Editor 13 April 2019 Pages: 1785 - 1787
A novel nucleotide substitution in the 5′ untranslated region of ANKRD26 gene is associated with inherited thrombocytopenia: a report of two new families Robert T. DiepKristin CoreyMurat O. Arcasoy Letter to the Editor 12 February 2019 Pages: 1789 - 1791
Multidimensional radar dot-plots, do we need it for the screening of acute promyelocytic leukemia? Emanuele AmmatunaGerwin Huls Letter to the Editor 25 April 2019 Pages: 1793 - 1794
EBV-positive mucocutaneous ulcer within colonic diverticulitis mimicking diffuse large B cell lymphoma Magda ZanelliMaurizio ZizzoStefano Ascani Letter to the Editor 15 May 2019 Pages: 1795 - 1797
Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission Tatsuya KonishiNoriko DokiKazuteru Ohashi Letter to the Editor 21 March 2019 Pages: 1799 - 1801
Correction to: Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma Semra PaydasAli OgulSerkan Gokcay Correction 03 June 2019 Pages: 1803 - 1803